Buy or sell Glooko stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Glooko Stock

Unified platform for Diabetes management

Founded

2010

Notable Investors

Mayo Clinic

Headquarters

Mountain View CA, US

Total Funding

$71.0M

About Glooko Stock

Glooko is the universal diabetes platform that provides insights to improve outcomes for people with diabetes (PWDs) and their care teams. Glooko connects to the world’s most popular diabetes devices, major fitness and activity trackers and supplies personalized, timely patient information such as glucose level, food, insulin, medications, blood pressure, diet and weight data. Trusted by the world’s leaders in diabetes care, we are in over 7,000 clinical locations and used by over 1.5 million PWDs in 23 countries across 15 languages. Learn more by visiting www.glooko.com.

Investors

Funding History

November 2010$1.0M
January 2012$3.5M
January 2014$7.0M
March 2015$16.5M
September 2016$8.0M
June 2017$35.0M

Management

Chief Executive Officer

Russ Johannesson

Co-Founder

Yogen Dalal

Chief Medical Officer

Michael S. Greenfield

Chief Commercial Officer

David Conn

Press

Other Companies

Logo
ChurnSpotter

ChurnSpotter detects your fragile customers

Logo
Dialpad Communications

Cloud-based business phone system

Logo
OmniSci

GPU-accelerated analytics

Logo
TrendKite

TrendKite is the Intelligent Communications Platform that puts earned media at the heart of the marketing mix.

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Glooko or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 70K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo

Logo